Association of Helicobacter pylori with central serous chorioretinopathy: hypotheses regarding pathogenesis
暂无分享,去创建一个
[1] S. Wessler,et al. Helicobacter pylori stimulates host vascular endothelial growth factor‐A (vegf‐A) gene expression via MEK/ERK‐dependent activation of Sp1 and Sp3 , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[2] M. Yuen,et al. Effects of primary metronidazole and clarithromycin resistance to Helicobacter pylori on omeprazole, metronidazole, and clarithromycin triple-therapy regimen in a region with high rates of metronidazole resistance. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[3] F. Cambien,et al. Impact of pathogen burden in patients with coronary artery disease in relation to systemic inflammation and variation in genes encoding cytokines. , 2003, The American journal of cardiology.
[4] Zheng Jiang,et al. Construction and characterization of bivalent vaccine candidate expressing HspA and M(r)18,000 OMP from Helicobacter pylori. , 2003, World journal of gastroenterology.
[5] J. Pulido,et al. Central serous chorioretinopathy associated with administration of sympathomimetic agents. , 2003, American journal of ophthalmology.
[6] T. Hikichi,et al. Features of abnormal choroidal circulation in central serous chorioretinopathy , 2003, The British journal of ophthalmology.
[7] J. Slakter,et al. INDOCYANINE GREEN ANGIOGRAPHY‐GUIDED PHOTODYNAMIC THERAPY FOR TREATMENT OF CHRONIC CENTRAL SEROUS CHORIORETINOPATHY: A Pilot Study , 2003, Retina.
[8] M. Byrne,et al. Helicobacter pylori binds von Willebrand factor and interacts with GPIb to induce platelet aggregation. , 2003, Gastroenterology.
[9] P. Heuschmann,et al. Detection of Chlamydia pneumoniae but not of Helicobacter pylori in symptomatic atherosclerotic carotids associated with enhanced serum antibodies, inflammation and apoptosis rate. , 2003, Atherosclerosis.
[10] J. Brophy,et al. Absence of Association Between Infectious Agents and Endothelial Function in Healthy Young Men , 2003, Circulation.
[11] U. Schmidt-Erfurth,et al. Characterization of leakage activity in exudative chorioretinal disease with three-dimensional confocal angiography. , 2003, Ophthalmology.
[12] G. Ferns,et al. Molecular mimicry in atherosclerosis: a role for heat shock proteins in immunisation. , 2003, Atherosclerosis.
[13] B. C. Wong,et al. Aspirin inhibits the growth of Helicobacter pylori and enhances its susceptibility to antimicrobial agents , 2003, Gut.
[14] Qingbo Xu,et al. Increased Risk of Atherosclerosis Is Confined to CagA-Positive Helicobacter pylori Strains: Prospective Results From the Bruneck Study , 2003, Stroke.
[15] L. Yannuzzi,et al. CYSTOID MACULAR DEGENERATION IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY , 2003, Retina.
[16] J. Atherton,et al. Stimulation of adhesion molecule expression by Helicobacter pylori and increased neutrophil adhesion to human umbilical vein endothelial cells , 2002, FEBS letters.
[17] F. Mégraud,et al. [Helicobacter pylori in central serous chorioretinopathy and diffuse retinal epitheliopathy. Results of the first prospective pilot study]. , 2002, Journal francais d'ophtalmologie.
[18] L. Yannuzzi,et al. Corticosteroids and central serous chorioretinopathy. , 2002, Ophthalmology.
[19] A. Gasbarrini,et al. Cross-Reactivity of Anti-CagA Antibodies With Vascular Wall Antigens: Possible Pathogenic Link Between Helicobacter pylori Infection and Atherosclerosis , 2002, Circulation.
[20] A. Quyyumi,et al. Predisposition to Atherosclerosis by Infections: Role of Endothelial Dysfunction , 2002, Circulation.
[21] C. Giusti. La corioretinopatia sierosa centrale: una nuova manifestazione extradigestiva dell'Helicobacter pylori? Analisi di un caso clinico , 2001 .
[22] D. Albert,et al. Principles and practice of ophthalmology , 1999 .
[23] H. Iijima,et al. Plasminogen activator inhibitor 1 in central serous chorioretinopathy. , 1999, American journal of ophthalmology.
[24] J. Flammer,et al. Choroidal capillary and venous congestion in central serous chorioretinopathy. , 1996, American journal of ophthalmology.